Leptin as a potential prognostic marker of the severity of COVID-19 infection in obese patients

dc.date.accessioned2022-03-23T16:54:20Z
dc.date.available2022-03-23T16:54:20Z
dc.date.created2022-03-23T16:54:20Z
dc.date.issued2022
dc.identifierhttps://hdl.handle.net/20.500.12866/11482
dc.identifierhttps://doi.org/10.1016/j.numecd.2021.12.003
dc.description.abstractWe read with great interest the article “Obesity as a risk factor for unfavorable outcomes in critically ill patients affected by COVID-19”, and we believe this is an important contribution toward understanding the relationship between the severity of the disease COVID-19 and obesity. Although we agree on the apparent role of adipokines, we believe that there is evidence suggesting that leptin may have a significant role in the underlying mechanisms of severe COVID-19 in obese patients due to its important immunological function...
dc.languageeng
dc.publisherElsevier
dc.relationNutrition, Metabolism and Cardiovascular Diseases
dc.relation1590-3729
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectCOVID-19
dc.subjecthuman
dc.subjectHumans
dc.subjectpandemic
dc.subjectcomputer assisted tomography
dc.subjectSARS-CoV-2
dc.subjectLetter
dc.subjectObesity
dc.subjectbody mass
dc.subjectobesity
dc.subjectprognosis
dc.subjectPrognosis
dc.subjectground glass opacity
dc.subjectleptin
dc.subjectLeptin
dc.subjectmonocyte
dc.subjectimmunoglobulin enhancer binding protein
dc.subjectobese patient
dc.titleLeptin as a potential prognostic marker of the severity of COVID-19 infection in obese patients
dc.typeinfo:eu-repo/semantics/article


Este ítem pertenece a la siguiente institución